Literature DB >> 22200861

Effects of lithium on oxidative stress parameters in healthy subjects.

Rushaniya Khairova1, Rohit Pawar, Giacomo Salvadore, Mario F Juruena, Rafael T de Sousa, Márcio G Soeiro-de-Souza, Mirian Salvador, Carlos A Zarate, Wagner F Gattaz, Rodrigo Machado-Vieira.   

Abstract

Increased neuronal oxidative stress (OxS) induces deleterious effects on signal transduction, structural plasticity and cellular resilience, mainly by inducing lipid peroxidation in membranes, proteins and genes. Major markers of OxS levels include the thiobarbituric acid reactive substances (TBARS) and the enzymes superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase. Lithium has been shown to prevent and/or reverse DNA damage, free-radical formation and lipid peroxidation in diverse models. This study evaluates OxS parameters in healthy volunteers prior to and following lithium treatment. Healthy volunteers were treated with lithium in therapeutic doses for 2-4 weeks. Treatment with lithium in healthy volunteers selectively altered SOD levels in all subjects. Furthermore, a significant decrease in the SOD/CAT ratio was observed following lithium treatment, which was associated with decreased OxS by lowering hydrogen peroxide levels. This reduction in the SOD/CAT ratio may lead to lower OxS, indicated primarily by a decrease in the concentration of cell hydrogen peroxide. Overall, the present findings indicate a potential role for the antioxidant effects of lithium in healthy subjects, supporting its neuroprotective profile in bipolar disorder (BD) and, possibly, in neurodegenerative processes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200861      PMCID: PMC3289682          DOI: 10.3892/mmr.2011.732

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  22 in total

Review 1.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

3.  The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.

Authors:  H P Misra; I Fridovich
Journal:  J Biol Chem       Date:  1972-05-25       Impact factor: 5.157

Review 4.  Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia.

Authors:  S P Mahadik; D Evans; H Lal
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-04       Impact factor: 5.067

Review 5.  Antioxidants, oxidative stress, and degenerative neurological disorders.

Authors:  R A Floyd
Journal:  Proc Soc Exp Biol Med       Date:  1999-12

6.  Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients.

Authors:  Prabhakar K Ranjekar; Ashwini Hinge; Mahabaleshwar V Hegde; Madhav Ghate; Anvita Kale; Sandhya Sitasawad; Ulhas V Wagh; Vijay B Debsikdar; Sahebarao P Mahadik
Journal:  Psychiatry Res       Date:  2003-12-01       Impact factor: 3.222

7.  Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells.

Authors:  J F Wang; J E Azzam; L T Young
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

8.  Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.

Authors:  C L Bowden; A M Brugger; A C Swann; J R Calabrese; P G Janicak; F Petty; S C Dilsaver; J M Davis; A J Rush; J G Small
Journal:  JAMA       Date:  1994 Mar 23-30       Impact factor: 56.272

9.  Mechanisms of lipid peroxide formation in animal tissues.

Authors:  E D Wills
Journal:  Biochem J       Date:  1966-06       Impact factor: 3.857

10.  Inhibition of glycogen synthase kinase 3 beta is involved in the resistance to oxidative stress in neuronal HT22 cells.

Authors:  Monika Schäfer; Sharon Goodenough; Bernd Moosmann; Christian Behl
Journal:  Brain Res       Date:  2004-04-16       Impact factor: 3.252

View more
  46 in total

Review 1.  Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach.

Authors:  Rodrigo Machado-Vieira; Marcio G Soeiro-De-Souza; Erica M Richards; Antonio L Teixeira; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-02       Impact factor: 4.132

2.  Oxidative stress in early stage Bipolar Disorder and the association with response to lithium.

Authors:  Rafael T de Sousa; Carlos A Zarate; Marcus V Zanetti; Alana C Costa; Leda L Talib; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  J Psychiatr Res       Date:  2013-12-06       Impact factor: 4.791

Review 3.  Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.

Authors:  Gin S Malhi; Tim Outhred
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

Review 4.  Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.

Authors:  O V Forlenza; V J R De-Paula; B S O Diniz
Journal:  ACS Chem Neurosci       Date:  2014-05-06       Impact factor: 4.418

5.  Na+/K+-ATPase level and products of lipid peroxidation in live cells treated with therapeutic lithium for different periods in time (1, 7, and 28 days); studies of Jurkat and HEK293 cells.

Authors:  Miroslava Vosahlikova; Lenka Roubalova; Hana Ujcikova; Martina Hlouskova; Stanislav Musil; Martin Alda; Petr Svoboda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-02-21       Impact factor: 3.000

6.  Tissue-specific protective properties of lithium: comparison of rat kidney, erythrocytes and brain.

Authors:  Lenka Roubalová; Miroslava Vošahlíková; Jiřina Slaninová; Jonáš Kaufman; Martin Alda; Petr Svoboda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-06       Impact factor: 3.000

Review 7.  Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.

Authors:  George Anderson; Michael Maes
Journal:  Curr Psychiatry Rep       Date:  2015-02       Impact factor: 5.285

Review 8.  [Oxidative stress in bipolar affective disorder].

Authors:  E Z Reininghaus; S Zelzer; B Reininghaus; N Lackner; A Birner; S A Bengesser; F T Fellendorf; H-P Kapfhammer; H Mangge
Journal:  Nervenarzt       Date:  2014-09       Impact factor: 1.214

Review 9.  Lithium in the Kidney: Friend and Foe?

Authors:  Mohammad Alsady; Ruben Baumgarten; Peter M T Deen; Theun de Groot
Journal:  J Am Soc Nephrol       Date:  2015-11-17       Impact factor: 10.121

10.  Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes.

Authors:  Rafael T de Sousa; Emilio L Streck; Marcus V Zanetti; Gabriela K Ferreira; Breno S Diniz; Andre R Brunoni; Geraldo F Busatto; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  Psychopharmacology (Berl)       Date:  2014-06-26       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.